Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Advanced Drug Delivery Reviews
|
September 4, 2021
Guiding immunotherapy combinations: Who gets what?
Michelle N Ferreira, Jennifer H Choe
Seminars in Radiation Oncology
|
March 16, 2025
Metastatic Head and Neck Cancer: Immunotherapy and Beyond
Kirsten V Nguyen, Cody M Lebeck Lee, Jennifer H Choe
European Thyroid Journal
|
December 14, 2023
Real-world practice patterns and outcomes for RAI-refractory differentiated thyroid cancer
Andrew G Gianoukakis, Jennifer H Choe, Daniel W Bowles, et al.
Journal of Vascular and Interventional Radiology : JVIR
|
October 11, 2022
Salvage Cryoablation for Local Recurrences of Thyroid Cancer Inseparable from the Trachea and Neurovascular Structures
Alan Alper Sag, Jennifer M Perkins, Hadiza S Kazaure, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 31, 2022
Phase Ia/b, Open-Label, Multicenter Study of AZD4635 (an Adenosine A2A Receptor Antagonist) as Monotherapy or Combined with Durvalumab, in Patients with Solid Tumors
Emerson A Lim, Johanna C Bendell, Gerald S Falchook, et al.
Journal of the National Cancer Institute
|
December 4, 2025
Cisplatin during radiation for head and neck cancer: insights from NRG Oncology experience
Luana G Sousa, James Edward Bates, Payal Anand, et al.
The Lancet. Oncology
|
October 24, 2023
Neoadjuvant cemiplimab and surgery for stage II-IV cutaneous squamous-cell carcinoma: follow-up and survival outcomes of a single-arm, multicentre, phase 2 study
Neil D Gross, David M Miller, Nikhil I Khushalani, et al.
Biorxiv : the Preprint Server for Biology
|
November 22, 2024
Tenascin-C potentiates Wnt signaling in thyroid cancer
Heather A Hartmann, Matthew A Loberg, George J Xu, et al.
The New England Journal of Medicine
|
September 12, 2022
Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma
Neil D Gross, David M Miller, Nikhil I Khushalani, et al.
Endocrinology
|
February 14, 2025
Tenascin-C Potentiates Wnt Signaling in Thyroid Cancer
Heather A Hartmann, Matthew A Loberg, George J Xu, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Advanced Drug Delivery Reviews
|
September 4, 2021
Guiding immunotherapy combinations: Who gets what?
Michelle N Ferreira, Jennifer H Choe
Seminars in Radiation Oncology
|
March 16, 2025
Metastatic Head and Neck Cancer: Immunotherapy and Beyond
Kirsten V Nguyen, Cody M Lebeck Lee, Jennifer H Choe
European Thyroid Journal
|
December 14, 2023
Real-world practice patterns and outcomes for RAI-refractory differentiated thyroid cancer
Andrew G Gianoukakis, Jennifer H Choe, Daniel W Bowles, et al.
Journal of Vascular and Interventional Radiology : JVIR
|
October 11, 2022
Salvage Cryoablation for Local Recurrences of Thyroid Cancer Inseparable from the Trachea and Neurovascular Structures
Alan Alper Sag, Jennifer M Perkins, Hadiza S Kazaure, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 31, 2022
Phase Ia/b, Open-Label, Multicenter Study of AZD4635 (an Adenosine A2A Receptor Antagonist) as Monotherapy or Combined with Durvalumab, in Patients with Solid Tumors
Emerson A Lim, Johanna C Bendell, Gerald S Falchook, et al.
Journal of the National Cancer Institute
|
December 4, 2025
Cisplatin during radiation for head and neck cancer: insights from NRG Oncology experience
Luana G Sousa, James Edward Bates, Payal Anand, et al.
The Lancet. Oncology
|
October 24, 2023
Neoadjuvant cemiplimab and surgery for stage II-IV cutaneous squamous-cell carcinoma: follow-up and survival outcomes of a single-arm, multicentre, phase 2 study
Neil D Gross, David M Miller, Nikhil I Khushalani, et al.
Biorxiv : the Preprint Server for Biology
|
November 22, 2024
Tenascin-C potentiates Wnt signaling in thyroid cancer
Heather A Hartmann, Matthew A Loberg, George J Xu, et al.
The New England Journal of Medicine
|
September 12, 2022
Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma
Neil D Gross, David M Miller, Nikhil I Khushalani, et al.
Endocrinology
|
February 14, 2025
Tenascin-C Potentiates Wnt Signaling in Thyroid Cancer
Heather A Hartmann, Matthew A Loberg, George J Xu, et al.
Page
of 2